| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | CEO | Director +1 more
3 companies
Tarriff Scott is a 10% Owner at EAGLE PHARMACEUTICALS, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 30 sells.
Estimated insider holdings value: $223K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2016 | EGRX Eagle Pharmaceuticals, Inc. | President And CEO | Sell | 18,360 | $68.08 | $1,249,974.34 | -0.3% | |
| Jan 4, 2016 | EGRX Eagle Pharmaceuticals, Inc. | President And CEO | Sell | 14,549 | $85.91 | $1,249,920.86 | -0.5% | |
| Dec 1, 2015 | EGRX Eagle Pharmaceuticals, Inc. | President And CEO | Sell | 14,050 | $88.93 | $1,249,418.92 | -0.2% | |
| Nov 2, 2015 | EGRX Eagle Pharmaceuticals, Inc. | President And CEO | Sell | 19,339 | $64.63 | $1,249,954.91 | -0.7% | |
| Oct 1, 2015 | EGRX Eagle Pharmaceuticals, Inc. | President And CEO | Sell | 17,878 | $69.92 | $1,249,964.73 | -0.2% | |
| Sep 1, 2015 | EGRX Eagle Pharmaceuticals, Inc. | President And CEO | Sell | 16,245 | $76.95 | $1,249,998.04 | -0.3% | |
| Aug 3, 2015 | EGRX Eagle Pharmaceuticals, Inc. | President And CEO | Sell | 13,000 | $96.19 | $1,250,408.26 | -0.4% | |
| Jul 1, 2015 | EGRX Eagle Pharmaceuticals, Inc. | President And CEO | Sell | 135,710 | $46.34 | $6,288,854.74 | -1.7% |